CorneaGen Annual Revenue, Number of Employees, Growth and Funding

Overview

Location:
Seattle, WA USA
Total Funding:N/A
Industry:Biotech
Founded:2016
Lead Investor(s):N/A
Press

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • CorneaGen's estimated annual revenue is currently $18.6M per year.
  • CorneaGen's estimated revenue per employee is $145,313

Employee Data

  • CorneaGen has 128 Employees.
  • CorneaGen grew their employee count by 32% last year.
  • CorneaGen currently has 10 job openings.

Executive Contacts

NameTitle
Cathy HaselSales Operations Director
Monty MontoyaPresident & CEO
Caroline HooverVP Operational Excellence
Tom MillerVP of Quality Assurance & Regulatory Affairs
Gretchen CokerChief Talent Management Officer
Vincent BriereVP, Technology Services
J.d. OsborneDirector of Sales
Brian McDevittDirector, Refractive Cornea
Lindsay GorangVP Finance
Erika PetersonDirector of Communications

CorneaGen is a mission-driven company committed to transforming how corneal surgeons treat and care for the cornea. Based in Seattle, the company is innovating the next generation of cornea care, from new medical devices and biologics to therapeutics and interventions. CorneaGen supports corneal surgeons and their patients with a spectrum of services, including the latest in innovative products, delivery of the highest quality tissue, surgeon education, and advocacy for patient access and reimbursement policies. www.corneagen.com. New CorneaGen offerings include tissue storage media with antifungal Ampho B, the Geuder Preloaded Glass Cannula for DMEK and Intacs® corneal implants for keratoconus. These products join the recently acquired AcuFocus KAMRA Inlay in CorneaGen's growing line of innovative and affordable therapeutics for corneal surgeons.

keywords:N/A

128

Number of Employees

$18.6M

Revenue (est)

10

Current Jobs

32%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Phytelligence
$12.7M88-15%N/A
RareCyte
$8.7M6015%N/A
Alpine Immune S...
$6.8M5619%N/A
NanoString Tech...
$85.1M58714%N/A
VMRD
$5.4M376%N/A
Global Medical ...
$6.2M4310%N/A
Inventprise
$6.2M438%N/A
Allen Institute...
$24.2M1675%N/A
Silverback Ther...
$5.6M3918%N/A
Arzeda
$5.1M3535%N/A

CorneaGen News

09/06/2019 - Innovative Report on Farsightedness Correction Market with ...

Market Segment by Companies, this report covers: CorneaGen, Revision Optics, Refocus, Presbia. Market Segment by Type, covers: Corneal ...

02/04/2019 - CorneaGen acquires KeraLink's US operations: An exclusive ...

CorneaGen and KeraLink today announced that CorneaGen will be acquiring all of KeraLink's U.S. eye bank operations and related assets.

04/05/2019 - VIDEO: CorneaGen's KeraLink integration nears completion

SCOTTSDALE, Ariz. - At the Cornea360 meeting, Monty Montoya, president and CEO of CorneaGen, discusses the company's integration of ...